There are 2789 resources available
806P - Genomic alteration characteristics and potential drug targets of uterine sarcoma
Presenter: Fengxia Xue
Session: ePoster Display
807P - Multi-centre study of escalated etoposide/cisplatin (Esc-EP) as a novel salvage regimen in advanced/refractory gestational trophoblastic neoplasia
Presenter: James Clark
Session: ePoster Display
808P - Characteristics and outcomes of women with adenocarcinoma versus squamous cell carcinoma of the vulva: A Japanese Gynecologic Oncology Group study
Presenter: Shin Nishio
Session: ePoster Display
809P - Comprehensive characterization of molecular features distinguishing uterine leiomyoma from leiomyosarcomas
Presenter: Xudong Liu
Session: ePoster Display
753P - Adverse events experienced by patients in the placebo arm of maintenance therapy trials in advanced ovarian cancer
Presenter: Sandy Simon
Session: ePoster Display
754P - Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer in Japan - GOTIC-019: A multi-institutional retrospective cohort study
Presenter: Shoji Nagao
Session: ePoster Display
755P - A machine learning approach applied to gynaecological ultrasound to predict progression-free survival in ovarian cancer patients
Presenter: Francesca Arezzo
Session: ePoster Display
756P - Efficacy of circulating tumor DNA (ctDNA) analysis in the early detection of ovarian cancer progression
Presenter: Jinho Heo
Session: ePoster Display
757P - Investigation of PARP inhibitor resistance through the analysis of serially collected circulating tumor DNA (ctDNA) in ovarian cancer patients
Presenter: Yoo-Na Kim
Session: ePoster Display
758P - Concordance between multiple HRD assays is substantial in high-grade ovarian cancer
Presenter: Wilko Weichert
Session: ePoster Display